Movement disorders induced by neuroleptic therapy.
DOI:
https://doi.org/10.20344/amp.3097Abstract
Neuroleptics are drugs frequently used in clinical psychiatric and neurologic daily practice. They share the ability to block postsynaptic dopamine D2 receptors in the Central Nervous System. Their potency is directly proportional to that block. Movement disorders are the most frequent and important adverse effects induced by these antipsychotic drugs. This work will highlight some of the essential aspects of distinct neuroleptic-induced movement disorders.Downloads
Downloads
How to Cite
Issue
Section
License
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
